GPW
ABBV icon

Gray Private Wealth’s AbbVie ABBV Stock Holding History

Gray Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$249K Buy
+991
New +$213K 0.11% 48

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gray Private Wealth's ABBV Position: Q2 2026 in Review

Gray Private Wealth opened a new position in AbbVie (ABBV) in Q2 2026: 991 shares worth $249K. The stake represents 0.11% of the portfolio and ranks #48 among its holdings.

4,191 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Gray Private Wealth held 991 shares of AbbVie worth $249K as of Q2 2026.
  • AbbVie was a new Gray Private Wealth position in Q2 2026.
  • AbbVie made up 0.11% of Gray Private Wealth's portfolio in Q2 2026, its #48 holding.
  • 4,191 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Gray Private Wealth's 13F filing for Q2 2026, filed 24 Jul 2026.